Literature DB >> 24035384

Interpretation of positive molecular tests of common viruses in the cerebrospinal fluid.

Archana Bhaskaran1, Lori Racsa, Rita Gander, Paul Southern, Dominick Cavuoti, Adnan Alatoom.   

Abstract

Many central nervous system infections are historically difficult to diagnose. Polymerase chain reaction (PCR) has revolutionized the diagnosis of these infections because of their high sensitivity despite the lack of data on clinical usefulness. We conducted a retrospective study that included patients with positive cerebrospinal fluid (CSF) PCR for herpes simplex virus, varicella-zoster virus, JC virus, cytomegalovirus (CMV), and Epstein-Barr virus (EBV) between January 2009 and December 2011. The positive results were grouped into definite, likely, and possible true positives and likely false-positive categories based on pre-specified definitions specific to each virus. Of 1663 CSF viral PCR tests, 88 were positive (5%). The combined positive predictive value (PPV) was 58%. The PPVs were least for CMV and EBV at 29 and 37%, respectively. A positive CSF viral PCR result has to be interpreted with caution due to several false-positive results.
© 2013.

Entities:  

Keywords:  CSF; False positive; PCR; Positive predictive value; Virus

Mesh:

Year:  2013        PMID: 24035384     DOI: 10.1016/j.diagmicrobio.2013.07.017

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.

Authors:  Craig B Wilen; Cynthia L Monaco; Joan Hoppe-Bauer; Ronald Jackups; Robert C Bucelli; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  Missing Cases of Herpes Simplex Virus (HSV) Infection of the Central Nervous System When the Reller Criteria Are Applied for HSV PCR Testing: a Multicenter Study.

Authors:  Eliseo Albert; Juan Alberola; Monserrat Bosque; Juan José Camarena; María Ángeles Clari; María Victoria Domínguez Márquez; María Gil-Fortuño; Adelina Gimeno; José Miguel Nogueira; María Dolores Ocete; Nieves Orta; Josep Prat; Juan Carlos Rodríguez; Isabel Valero; Concepción Gimeno Cardona; David Navarro
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

3.  Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Clemens Warnke; Gloria von Geldern; Philipp Markwerth; Thomas Dehmel; Robert Hoepner; Ralf Gold; Michael Pawlita; Tania Kümpfel; Mathias Mäurer; Martin Stangel; Florian Wegner; Reinhard Hohlfeld; Vera Straeten; Volker Limmroth; Thomas Weber; Derik Hermsen; Christoph Kleinschnitz; Hans-Peter Hartung; Mike P Wattjes; Anders Svenningson; Eugene Major; Tomas Olsson; Bernd C Kieseier; Ortwin Adams
Journal:  Ann Neurol       Date:  2014-05-08       Impact factor: 10.422

4.  A review of a 13-month period of FilmArray Meningitis/Encephalitis panel implementation as a first-line diagnosis tool at a university hospital.

Authors:  Agathe Boudet; Alix Pantel; Marie-Josée Carles; Hélène Boclé; Sylvie Charachon; Cécilia Enault; Robin Stéphan; Lucile Cadot; Jean-Philippe Lavigne; Hélène Marchandin
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

Review 5.  Acyclovir-induced neurotoxicity with a positive cerebrospinal fluid varicella zoster PCR result creating a management dilemma: a case report.

Authors:  Kelli M Robertson; Christopher L Harvey; John M Cunningham
Journal:  J Med Case Rep       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.